Drug Utilization Review Board

Regulatory
July 27, 2022
  • Twitter
  • Facebook
  • Google+
  • Linkedin
Drug Utilization Review Board develops and submits recommendations for the preferred drug list, suggests clinical prior authorizations on outpatient prescription drugs, recommends education interventions for Medicaid providers, and reviews drug usage across Medicaid programs. Physicians and pharmacists Alejandro D. Kudisch, M.D., D.F. A.P.A. (McAllen) (Chair) Term ends Aug. 31, 2022 Jennifer Fix, Pharm. D (Burleson) (Vice-chair) Term ends Aug. 31, 2022 Scott Blaszczyk, Pharm.D., BCGP (Dallas) Marlo Brawner, M.D. (Livingston) Dominique Brewster, Pharm.D, BCPS, BCGP, AAHIVP (Houston) Deborah E. Briggs, M.D. (Austin) Robert L. Hogue, M.D., F.A.A.F.M. (Brownwood) Heather Holmes, M.D. (Amarillo) Joshua R. Tonche-Johns, Pharm. D. (Richardson) Sarah E. Kubes, Pharm. D. (San Antonio) Jill N. Lester, Pharm. D. (Dallas) Brigetta Martinez, Pharm. D., BCPPS, MASPHM (Edinburg) Richard Noel, M.D. (Spring) Kim Pham, D.O. (Dallas)

Subscribe to gain full access to all of our must-have reports and videos

OR

Log in